We know that women who experience stroke are more likely than men to initially be given a non-stroke diagnosis, and this could be because they don’t always display what could be considered the ‘classical’ symptoms of stroke as often as men do.

According to World Stroke Organization WSO: Incidence and Prevalence for all Stroke Types Combined in Women with all ages estimated 6,437,105. Crude rate per 100,000 per year: 166.92 (150.75-185.90) Age-adjusted rate per 100,000 per year: 149.75 (135.58-166.56). Each year, 53% of all strokes occur in women. 56% of people who have experienced a stroke and are currently living are women.

What is a stroke?

A stroke happens when blood flow to an area of the brain is blocked or when a blood vessel in the brain bursts. Blood carries oxygen to cells in the body. When brain cells are starved of blood, they die.

Stroke is a medical emergency. It’s important to get treatment as soon as possible (see sidebar). Some treatments for stroke work only if given within the first 3 hours after symptoms start. A delay in treatment increases the risk of permanent brain damage or death.

What Are the Differences in Stroke Symptoms Between Women and Men?

During a stroke, both men and women typically report these signs appearing suddenly:

Women, however, may also report these symptoms: 

What puts women at risk for stroke?

High blood pressure, also called hypertension, is a main risk factor for stroke. More than 2 in 5 women have blood pressure greater than or equal to 130/80 mm Hg or are taking medicine to control their blood pressure. Only about 1 in 4 of those women have their blood pressure controlled to below 130/80 mm Hg. Stroke risk increases with age, and women live longer than men.

Women also have unique risk factors for stroke, including:

• Having high blood pressure during pregnancy.
• Using certain types of birth control medicines, especially if they also smoke. About 1 in 8 women smoke.
• Having higher rates of depression. 

Cardiac biomarkers such as cardiac troponin (cTn), brain natriuretic peptide (BNP), D-dimer, CK-MB, Myoglobin, N-terminal pro-brain natriuretic peptide (NT-proBNP),Lipoprotein-associated phospholipase A 2 (Lp-PLA2) and ST2 have been frequently reported in patients undergoing a heart failure and a stroke.

At Biotime, you can find chest pain and stroke related full range of cardiac biomarkers list which are the quick aid. 3 in 1 and 5 in 1 Combo testings are even more productively efficient and highly scaled testing parameters where the results provided within 20 minutes.

we implement cardiac biomarkers in routine practice to:

• Reduce time to diagnosis and improve patient care                                                                                                                                                    

• Shorten the length of stay in the emergency department by nearly 80 minutes and has the potential to contribute to cost savings 

• Associated with more efficient allocation of imaging and faster patient turnover in the emergency department

Your benefits of choosing Pure Biotime products:

• Designed for high sensitivity: High sensitivity minimizes the probability of misdiagnosing                                                                                                  

• Cost efficiency: High specificity reduces the need for re-testing

• Clear results interpretation: Clear cut-off separation of positive and negative results

• Efficient use of sample volume: Maximizes the chance to order all the tests required from the same sample

• Low sample volume: High analytical sensitivity allows low sample volumes

• Rapid response times

Reference:

1. Greenlund K, et al. (2003). 

2. Mueller, C. et al. (2016). Annal Emerg Med.;68(1):76-87.

3. More strokes for men; More deadly for women. (n.d.).

4. Twerenbold, R. et al. (2016). Eur Heart J. 2016 Nov 21; 37(44):3324-3332.

5. Chengyang Xu. et al. (2020).Molecular Sci J. 2020 Feb 21(7), 2347.

6. https://www.xiamenbiotime.com/